Febit has named Jack Leonard its vice president of technology commercialization.
In the role, Leonard will help “expand the company’s capabilities to serving the US life sciences market with miRNA and gene-expression profiling technology and services,” Febit said.
Leonard previously served as director of genomics and molecular biology at Millipore. He holds a PhD in genetics from the University of Connecticut.
NovaRx, a developer of cell-based cancer vaccines,has named Norrie Russell as its president and COO.
Russell previously served as CSO of Invitrogen. He also held various positions at AstraZeneca, including global head of biological science and technology.
BioNanomatrix, a developer of whole-genome imaging and analysis systems, has appointed Gary Zweiger as its vice president of business development.
Zweiger previously served as director of business development at Applied Biosystems’ cell and molecular biology division where he managed collaborations and business-development activities for, among other things, the company’s RNAi operations.